Evidence map›Paper›PMID 38230317›Full record

ArticleCentral European journal of urology2023

The influence of the operator's experience on the outcomes of fusion prostate biopsy.

Grzegorz Rempega, Paweł Rajwa, Jakub Ryszawy, Jakub Wojnarowicz, Maksymilian Kowalik, Marcela Krzempek, Aleksandra Krzywon, Michał Dobrakowski, Ewa Fil, Bartłomiej Burzyński and 2 more

Open access · greenAbstract read
In one paragraph

Article in Central European journal of urology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Grzegorz RempegaDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Paweł RajwaDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Jakub RyszawyDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Jakub WojnarowiczDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Maksymilian KowalikDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Marcela KrzempekDepartment of Biostatistics and Bioinformatics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Aleksandra KrzywonDepartment of Biostatistics and Bioinformatics, Maria Skłodowska-Curie National Research Institute of Oncology, Gliwice Branch, Gliwice, Poland.
Michał DobrakowskiDepartment of Biochemistry, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Ewa FilGlivestetic, Gliwice, Poland.
Bartłomiej BurzyńskiDepartment of Rehabilitation, Faculty of Health Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland.
Andrzej ParadyszDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Piotr BryniarskiDepartment of Urology, Division of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Zabrze, Poland.
Medical University of Silesia · PLThe Maria Sklodowska-Curie National Research Institute of Oncology · PLŁukasiewicz Research Network - Institute of Welding · PLMedical University of Vienna · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Magnetic resonance imgaing (MRI) targeted biopsy is the gold standard for prostate cancer (PCa) diagnosis. In this study, we examined the association between the operator's experience and the improvement in the precision of the MRI prostate biopsy procedure and the detection of PCa. Material and methods: We included consecutive patients who underwent prostate fusion biopsy. Data on biopsy duration, prostate-specific antigen (PSA) value, lesion size, number of samples taken, number of cores involved, and International Society of Urological Pathology (ISUP) grade were subjected to statistical analysis, with the study group divided into three consecutive time periods (tertiles). Results: There were statistically significant differences in biopsy duration between tertiles (p <0.001). The greatest difference in the involved/taken cores ratio occurred between the first and third tertile (p = 0.002). The difference between the first and second tertile was insignificant (p = 0.4), while the difference between the second and third tertile was statistically significant (p = 0.004). The differences between tertiles in Prostate Imaging and Reporting Data System v2.1 were also significant (p = 0.003). The PSA value (p = 0.036) was statistically significant, unlike prostate volume (p = 0.16), digital rectal examination (DRE) (p = 0.7), and ISUP grade (p = 0.7). There was no statistical difference between tested tertiles in the number of detected PCa ISUP ≥2 (Z = 0.191; p = 0.8). Conclusions: The abilities and precision of the operator increase with the increase in the number of procedures performed. The biopsy duration is shortened, and the detection of PCa during the procedure seems to improve with the operator's experience.

Indexed as

biopsyimage-guided biopsyprostate cancer

Identifiers

PMID38230317
PMCPMC10789274
OpenAlexW4386939441

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.